Patrys Limited (PAB.AX)

AUD 0.0

(0.0%)

Operating Expenses Summary of Patrys Limited

  • Patrys Limited's latest annual operating expenses in 2024 was 4.93 Million AUD , down -49.73% from previous year.
  • Patrys Limited's latest quarterly operating expenses in 2024 FY was 4.87 Million AUD , down -50.34% from previous quarter.
  • Patrys Limited reported a annual operating expenses of 9.81 Million AUD in annual operating expenses 2023, down -13.57% from previous year.
  • Patrys Limited reported a annual operating expenses of 11.35 Million AUD in annual operating expenses 2022, up 94.51% from previous year.
  • Patrys Limited reported a quarterly operating expenses of 4.87 Million AUD for 2024 FY, down -50.34% from previous quarter.
  • Patrys Limited reported a quarterly operating expenses of 2.31 Million AUD for 2024 Q4, down 0.0% from previous quarter.

Annual Operating Expenses Chart of Patrys Limited (2024 - 2007)

Historical Annual Operating Expenses of Patrys Limited (2024 - 2007)

Year Operating Expenses Operating Expenses Growth
2024 4.93 Million AUD -49.73%
2023 9.81 Million AUD -13.57%
2022 11.35 Million AUD 94.51%
2021 5.83 Million AUD 68.05%
2020 3.47 Million AUD 176.63%
2019 1.25 Million AUD -58.39%
2018 3.01 Million AUD 27.57%
2017 2.36 Million AUD 19.67%
2016 1.97 Million AUD -68.68%
2015 6.31 Million AUD -26.48%
2014 8.58 Million AUD 60.61%
2013 5.34 Million AUD -32.79%
2012 7.95 Million AUD -14.11%
2011 9.26 Million AUD -8.54%
2010 10.12 Million AUD -14.94%
2009 11.9 Million AUD 42.42%
2008 8.35 Million AUD 0.0%
2007 - AUD 0.0%

Peer Operating Expenses Comparison of Patrys Limited

Name Operating Expenses Operating Expenses Difference
EZZ Life Science Holdings Limited 39.57 Million AUD 87.534%
Anatara Lifesciences Ltd 710.21 Thousand AUD -594.621%
Zelira Therapeutics Limited 5.94 Million AUD 17.066%
Biome Australia Limited 7.91 Million AUD 37.642%
Orthocell Limited 15.36 Million AUD 67.902%
Imugene Limited 135.09 Million AUD 96.348%
Noxopharm Limited 7 Million AUD 29.526%
PYC Therapeutics Limited 60.91 Million AUD 91.902%
Chimeric Therapeutics Limited 19.76 Million AUD 75.043%
Prescient Therapeutics Limited 10.89 Million AUD 54.735%
Proteomics International Laboratories Limited 892.14 Thousand AUD -452.973%
Cynata Therapeutics Limited 11.12 Million AUD 55.65%
CSL Limited 7.56 Billion AUD 99.935%
Arovella Therapeutics Limited 10.78 Million AUD 54.259%
Bio-Gene Technology Limited 2.76 Million AUD -78.678%
Clinuvel Pharmaceuticals Limited 31.29 Million AUD 84.237%
Starpharma Holdings Limited 22.81 Million AUD 78.378%
Nanollose Limited 12.5 Thousand AUD -39363.347%
Memphasys Limited 3.67 Million AUD -34.116%
Invex Therapeutics Ltd 3.34 Million AUD -47.444%
NeuroScientific Biopharmaceuticals Limited 1.96 Million AUD -151.031%
Amplia Therapeutics Limited 8.43 Million AUD 41.519%
Botanix Pharmaceuticals Limited 601.82 Thousand AUD -719.732%
Island Pharmaceuticals Limited 4.12 Million AUD -19.585%
Race Oncology Limited 14.77 Million AUD 66.6%
Nyrada Inc. 4.55 Million AUD -8.301%
Telix Pharmaceuticals Limited 269.26 Million AUD 98.168%
Dimerix Limited 25.64 Million AUD 80.762%
PharmAust Limited 6.65 Million AUD 25.893%
Immutep Limited 42.87 Million AUD 88.494%
Clarity Pharmaceuticals Ltd 56.3 Million AUD 91.239%
Alterity Therapeutics Limited 23.4 Million AUD 78.923%
BTC Health Limited -1.03 Million AUD 574.847%
Acrux Limited 8.55 Million AUD 42.3%
Neuren Pharmaceuticals Limited 32.69 Million AUD 84.912%
Biotron Limited 5.11 Million AUD 3.47%
Tissue Repair Ltd 6.66 Million AUD 26.002%
AdAlta Limited 6.76 Million AUD 27.124%
Radiopharm Theranostics Limited 299.22 Thousand AUD -1548.68%
Hexima Limited 1 Million AUD -389.052%
AnteoTech Limited 12.18 Million AUD 59.52%
Paradigm Biopharmaceuticals Limited 65.1 Million AUD 92.422%
Recce Pharmaceuticals Ltd 21.68 Million AUD 77.25%
Avecho Biotechnology Limited 4.54 Million AUD -8.534%
Actinogen Medical Limited 22.77 Million AUD 78.335%
Immuron Limited 9.13 Million AUD 46.013%
Argenica Therapeutics Limited 8.26 Million AUD 40.341%